Clinical Trial Results:
Effect of the plasma substitutes Gelofusine and Hydroxyethyl Starch 130/0.4 combined with lactated ringer's solution on the coagulation system
Summary
|
|
EudraCT number |
2011-000156-42 |
Trial protocol |
NL |
Global completion date |
28 Oct 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
15 Nov 2021
|
First version publication date |
15 Nov 2021
|
Other versions |
|
Summary report(s) |
Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: A randomized controlled trial June 2013Perfusion Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: A randomized controlled trial June 2013Perfusion |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.